Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1995 Aug;79(8):771–776. doi: 10.1136/bjo.79.8.771

Immunohistochemical evidence of neuronal and glial differentiation in retinoblastoma.

K P Xu 1, S L Liu 1, C Ni 1
PMCID: PMC505249  PMID: 7547791

Abstract

BACKGROUND--The study sought to investigate the histogenesis of retinoblastoma. METHODS--One hundred specimens of retinoblastomas were examined along with those of 18 astrocytic gliomas and 15 medulloblastomas to compare similarities of glial differentiation in retinoblastoma and the two types of brain tumour. Employing avidin-biotin immunoperoxidase technique, antibodies were applied against neuron specific enolase (NSE), glial fibrillary acidic protein (GFAP), and S-100 protein (S-100). RESULTS--Most rosettes and fleurettes, and some undifferentiated cells in retinoblastomas were NSE positive, but GFAP and S-100 negative. GFAP and S-100 positive cells in retinoblastomas were detected mostly in well differentiated glial cells which were interpreted as reactive or non-neoplastic cells. Some of the GFAP and S-100 positive cells in retinoblastomas were defined as tumour cells that resembled neoplastic astrocytes in astrocytic gliomas and medulloblastomas. CONCLUSION--Retinoblastoma may arise from primitive bipotential or multipotential cells capable of neuronal and glial differentiation.

Full text

PDF
771

Images in this article

772Image
on p.772
773Image
on p.773
773Image
on p.773
775Image
on p.775
775Image
on p.775

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cochran A. J., Holland G. N., Wen D. R., Herschman H. R., Lee W. R., Foos R. Y., Straatsma B. R. Detection of cytoplasmic S-100 protein in primary and metastatic intraocular melanomas. Invest Ophthalmol Vis Sci. 1983 Aug;24(8):1153–1155. [PubMed] [Google Scholar]
  2. Craft J. L., Sang D. N., Dryja T. P., Brockhurst R. J., Robinson N. L., Albert D. M. Glial cell component in retinoblastoma. Exp Eye Res. 1985 May;40(5):647–659. doi: 10.1016/0014-4835(85)90134-4. [DOI] [PubMed] [Google Scholar]
  3. Eng L. F., Rubinstein L. J. Contribution of immunohistochemistry to diagnostic problems of human cerebral tumors. J Histochem Cytochem. 1978 Jul;26(7):513–522. doi: 10.1177/26.7.357640. [DOI] [PubMed] [Google Scholar]
  4. Gonzalez-Fernandez F., Lopes M. B., Garcia-Fernandez J. M., Foster R. G., De Grip W. J., Rosemberg S., Newman S. A., VandenBerg S. R. Expression of developmentally defined retinal phenotypes in the histogenesis of retinoblastoma. Am J Pathol. 1992 Aug;141(2):363–375. [PMC free article] [PubMed] [Google Scholar]
  5. He W., Hashimoto H., Tsuneyoshi M., Enjoji M., Inomata H. A reassessment of histologic classification and an immunohistochemical study of 88 retinoblastomas. A special reference to the advent of bipolar-like cells. Cancer. 1992 Dec 15;70(12):2901–2908. doi: 10.1002/1097-0142(19921215)70:12<2901::aid-cncr2820701229>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  6. Kivelä T. Neuron-specific enolase in retinoblastoma. An immunohistochemical study. Acta Ophthalmol (Copenh) 1986 Feb;64(1):19–25. doi: 10.1111/j.1755-3768.1986.tb06866.x. [DOI] [PubMed] [Google Scholar]
  7. Kivelä T., Tarkkanen A., Virtanen I. Intermediate filaments in the human retina and retinoblastoma. An immunohistochemical study of vimentin, glial fibrillary acidic protein, and neurofilaments. Invest Ophthalmol Vis Sci. 1986 Jul;27(7):1075–1084. [PubMed] [Google Scholar]
  8. Lane J. C., Klintworth G. K. A study of astrocytes in retinoblastomas using the immunoperoxidase technique and antibodies to glial fibrillary acidic protein. Am J Ophthalmol. 1983 Feb;95(2):197–207. doi: 10.1016/0002-9394(83)90014-4. [DOI] [PubMed] [Google Scholar]
  9. Messmer E. P., Font R. L., Kirkpatrick J. B., Höpping W. Immunohistochemical demonstration of neuronal and astrocytic differentiation in retinoblastoma. Ophthalmology. 1985 Jan;92(1):167–173. doi: 10.1016/s0161-6420(85)34076-9. [DOI] [PubMed] [Google Scholar]
  10. Molnar M. L., Stefansson K., Marton L. S., Tripathi R. S., Molnar G. K. Immunohistochemistry of retinoblastomas in humans. Am J Ophthalmol. 1984 Mar;97(3):301–307. doi: 10.1016/0002-9394(84)90627-5. [DOI] [PubMed] [Google Scholar]
  11. Nakajima T., Kameya T., Tsumuraya M., Shimosato Y., Kato K. Enolase distribution in human brain tumors, retinoblastomas and pituitary adenomas. Brain Res. 1984 Aug 13;308(2):215–222. doi: 10.1016/0006-8993(84)91060-6. [DOI] [PubMed] [Google Scholar]
  12. Perentes E., Herbort C. P., Rubinstein L. J., Herman M. M., Uffer S., Donoso L. A., Collins V. P. Immunohistochemical characterization of human retinoblastomas in situ with multiple markers. Am J Ophthalmol. 1987 May 15;103(5):647–658. doi: 10.1016/s0002-9394(14)74324-7. [DOI] [PubMed] [Google Scholar]
  13. Schmechel D., Marangos P. J., Brightman M. Neurone-specific enolase is a molecular marker for peripheral and central neuroendocrine cells. Nature. 1978 Dec 21;276(5690):834–836. doi: 10.1038/276834a0. [DOI] [PubMed] [Google Scholar]
  14. Schmechel D., Marangos P. J., Zis A. P., Brightman M., Goodwin F. K. Brain endolases as specific markers of neuronal and glial cells. Science. 1978 Jan 20;199(4326):313–315. doi: 10.1126/science.339349. [DOI] [PubMed] [Google Scholar]
  15. Shields J. A., Augsburger J. J. Current approaches to the diagnosis and management of retinoblastoma. Surv Ophthalmol. 1981 May-Jun;25(6):347–372. doi: 10.1016/0039-6257(81)90072-2. [DOI] [PubMed] [Google Scholar]
  16. Shuangshoti S., Chaiwun B., Kasantikul V. A study of 39 retinoblastomas with particular reference to morphology, cellular differentiation and tumour origin. Histopathology. 1989 Aug;15(2):113–124. doi: 10.1111/j.1365-2559.1989.tb03059.x. [DOI] [PubMed] [Google Scholar]
  17. Takayama S., Yamomoto M., Ito H. [27 cases of retinoblastoma--pathological and immunohistological studies]. Nippon Ganka Gakkai Zasshi. 1985 Jul;89(7):797–803. [PubMed] [Google Scholar]
  18. Tarlton J. F., Easty D. L. Immunohistological characterisation of retinoblastoma and related ocular tissue. Br J Ophthalmol. 1990 Mar;74(3):144–149. doi: 10.1136/bjo.74.3.144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Terenghi G., Polak J. M., Ballesta J., Cocchia D., Michetti F., Dahl D., Marangos P. J., Garner A. Immunocytochemistry of neuronal and glial markers in retinoblastoma. Virchows Arch A Pathol Anat Histopathol. 1984;404(1):61–73. doi: 10.1007/BF00704251. [DOI] [PubMed] [Google Scholar]
  20. Ts'o M. O., Fine B. S., Zimmerman L. E. The nature of retinoblastoma. II. Photoreceptor differentiation: an electron microscopic study. Am J Ophthalmol. 1970 Mar;69(3):350–359. doi: 10.1016/0002-9394(70)92264-6. [DOI] [PubMed] [Google Scholar]
  21. Ts'o M. O., Zimmerman L. E., Fine B. S., Ellsworth R. M. A cause of radioresistance in retinoblastoma: photoreceptor differentiation. Trans Am Acad Ophthalmol Otolaryngol. 1970 Sep-Oct;74(5):959–969. [PubMed] [Google Scholar]
  22. Ts'o M. O., Zimmerman L. E., Fine B. S. The nature of retinoblastoma. I. Photoreceptor differentiation: a clinical and histopathologic study. Am J Ophthalmol. 1970 Mar;69(3):339–349. doi: 10.1016/0002-9394(70)92263-4. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES